Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 5, 2001

View Archived Issues

Nexell awarded orphan drug status for stem cell product

Valentis acquires electroporation technology license from Genetronics

Abgenix licenses novel cancer target for development of potential antibody therapies

Elan highlights oncology portfolio

Encouraging results from phase I study of inhalable leuprolide

Alista associated with positive results in female sexual dysfunction

Affitech and Axaron form strategic alliance for genomics-based antibody drugs

Praecis proceeds with clinical plans for Plenaxis following discussions with the FDA

Research snapshots in neuroprotection

Second approval for first oral drug for the treatment of PAH

Cephalon announces agreement to acquire French pharmaceutical company

Regulatory update on Glivec/Gleevec

Further characterization of the bronchodilating effects of Ro-25-1553 in human preparations

Expression of mda-7 gene downregulated in advanced human melanomas; INGN-241 blocks growth

VNS effective and safe in chronic or recurrent treatment-resistant depression

PH-50: a promising new vascular imaging agent from Photogen

Long-term pegvisomant beneficial in acromegaly

Fusion proteins useful for DC-based immunotherapy of tumors

Delivery of polynucleotides into cells using histones under study at Biogeny

Sankyo discloses new triazole antifungal agents in recent patent

New broad-spectrum antibacterial agents in the GSK pipeline

Antiinflammatory and analgesic effects demonstrated for new PLA2 inhibitors

Cyclooxygenase inhibitors synthesized at Takeda useful for inflammation, pain and fever

Recent patent covers oxytocin receptor ligands identified at Sanofi-Synthelabo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026